GRIO


BREUIL

Pr Véronique BREUIL

Comité scientifique du GRIO


Présentation > Les membres du Comité Directeur > Pr Véronique BREUIL > Publications

PUBLICATIONS RÉCENTES


Roux C, Fontas E, Breuil V, Brocq O, Albert C, Euller-Ziegler L. Injection of intra-articular sodium hyaluronidate (Sinovial) into the carpometacarpal joint of the thumb (CMC1) in osteoarthritis. A prospective evaluation of efficacy. Joint Bone Spine. 2007;74(4):368-72

Brocq O, Roux CH, Albert C, Breuil V, Aknouche N, Ruitord S, Mousnier A, Euller-Ziegler L. TNFalpha antagonist continuation rates in 442 patients with inflammatory joint disease. Joint Bone Spine. 2007;74(2):148-54

Roux CH, Brocq O, Leccia N, Giacchero D, Breuil V, Albert C, Lacour J, Perrin C, Euler-Ziegler L. New-onset psoriatic palmoplantaris pustulosis following infliximab therapy: a class effect? J Rheumatol. 2007;34(2):434-7.

Roux CH, Brocq O, Breuil V, Albert C, Euller-Ziegler L. Pregnancy in rheumatology patients exposed to anti-tumour necrosis factor (TNF)-alpha therapy. Rheumatology (Oxford). 2007;46(4):695-8

Roux CH, Breuil V, Brocq O, Albert C, Chami H, Euller-Ziegler L. Hyperamylasemia and back pain: an exceptional association revealing multiple myeloma. Joint Bone Spine. 2007;74(1):112-3

Breuil V, Euller-Ziegler L. Bisphosphonate therapy in rheumatoid arthritis. Joint Bone Spine. 2006;73(4):349-54

Roux CH, Brocq O, Breuil V, Albert C, Euller-Ziegler L. Safety of anti-TNF-alpha therapy in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic hepatitis. Rheumatology (Oxford). 2006;45(10):1294-7

Roux CH, Chami H, Breuil V, Brocq O, Albert C, Euller-Ziegler L. Lumbosacral pain: chordoma--a diagnosis not to forget. Clin Rheumatol. 2007;26(5):781-3

Blin-Wakkach C, Breuil V, Quincey D, Bagnis C, Carle GF. Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice. Bone. 2006;39(1):53-60

Roux CH, Breuil V, Brocq O, Euller-Ziegler L. Pleural amyloidosis as the first sign of IgD multiple myeloma. Clin Rheumatol. 2005;24(3):294-5

Brocq O, Albert C, Roux C, Gerard D, Breuil V, Ziegler LE. Adalimumab in rheumatoid arthritis after failed infliximab and/or etanercept therapy: experience with 18 patients. Joint Bone Spine. 2004;71(6):601-3

Vitale S, Schmid-Alliana A, Breuil V, Pomeranz M, Millet MA, Rossi B, Schmid-Antomarchi H. Soluble fractalkine prevents monocyte chemoattractant protein-1-induced monocyte migration via inhibition of stress-activated protein kinase 2/p38 and matrix metalloproteinase activities. J Immunol. 2004;172(1):585-92

Breuil V, Schmid-Antomarchi H, Schmid-Alliana A, Rezzonico R, Euller-Ziegler L, Rossi B. The receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) is a new chemotactic factor for human monocytes. FASEB J. 2003;17(12):1751-3

Brocq O, Tran G, Breuil V, Grisot C, Flory P, Euller-Ziegler L. Hip osteoarthritis: short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label study in 22 patients. Joint Bone Spine. 2002;69(4):388-91

Rezzonico R, Schmid-Alliana A, Romey G, Bourget-Ponzio I, Breuil V, Breittmayer V, Tartare-Deckert S, Rossi B, Schmid-Antomarchi H. Prostaglandin E2 induces interaction between hSlo potassium channel and Syk tyrosine kinase in osteosarcoma cells. J Bone Miner Res. 2002;17(5):869-78

Breuil V, Brocq O, Pellegrino C, Grimaud A, Euller-Ziegler L. Erdheim-Chester disease: typical radiological bone features for a rare xanthogranulomatosis. Ann Rheum Dis. 2002;61(3):199-200

Breuil V, Euller-Ziegler L. Gonadal dysgenesis and bone metabolism. Joint Bone Spine. 2001;68(1):26-33

Xia L, Kilb J, Wex H, Li Z, Lipyansky A, Breuil V, Stein L, Palmer JT, Dempster DW, Brömme D. Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones. Biol Chem. 1999;380(6):679-87

Dernière mise à jour : 17-01-2017